Cleavage of 14-3-3ϵ by the enteroviral 3C protease dampens RIG-I mediated antiviral signaling
D. D. Andrews, Y. Mohamud, M. Vlok, D. Akbari Bani, B. N. Hay, L. J. Foster, H. Luo, C. M. Overall, E. Jan
Abstract
Viruses have evolved diverse strategies to evade the host innate immune response and promote infection. The RIG-I-like-receptors RIG-I and MDA5 (RLRs) are antiviral factors that sense viral RNA and signal downstream via mitochondrial antiviral-signaling protein (MAVS) to activate type I interferon (IFN) expression. 14-3-3{varepsilon} is a key component of the RIG-I translocon complex that interacts with MAVS at the mitochondrial membrane; however, the exact role of 14-3-3{varepsilon} in this pathway is not well understood. In this study, we demonstrate that 14-3-3{varepsilon} is a direct substrate of both the poliovirus and coxsackievirus B3 (CVB3) 3C proteases (3Cpro), and that it is cleaved at Q236{downarrow}G237, resulting in the generation of N- and C-terminal fragments of 27.0 and 2.1 kDa, respectively. Expression of the N-terminal cleavage fragment in cells reduces IFNB mRNA production during poly(I:C) stimulation, thus suggesting an antagonistic effect in the presence of the endogenous 14-3-3{varepsilon} protein. The N-terminal 14-3-3{varepsilon} fragment does not interact with RIG-I in co-immunoprecipitation assays, nor can it facilitate RIG-I translocation to the mitochondria. Probing the intrinsically disordered C-terminal region identifies key residues responsible for RIG-I signaling. Finally, overexpression of the N-terminal fragment promotes CVB3 infection and influenza A virus (H1N1) RNA production and reduces IFNB mRNA production during infection. The strategic enterovirus 3Cpro-mediated cleavage of 14-3-3{varepsilon} antagonizes RIG-I signaling by disrupting critical interactions within the RIG-I translocon complex, thus contributing to evasion of the host antiviral response. Author SummaryHost antiviral factors work to sense virus infection through various mechanisms, including a complex signaling pathway known as the RIG-I like receptor (RLR) pathway. This pathway drives the production of antiviral molecules known as interferons, which are necessary to establish an antiviral state in the cellular environment. Key to this antiviral signaling pathway is the small chaperone protein 14-3-3{varepsilon}, which facilitates the delivery of a viral sensor protein, RIG-I, to the mitochondria. In this study, we show that the enteroviral 3C protease cleaves 14-3-3{varepsilon} during infection, rendering it incapable of facilitating this antiviral response. We also find that the cleavage fragment inhibits RIG-I signaling and promotes virus infection. Our findings reveal a novel viral strategy that restricts the antiviral host response and provides insights into the mechanisms underlying 14-3-3{varepsilon} function in RIG-I antiviral signaling.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The reovirus σ3 protein induces proteasomal degradation of IKKβ to modulate the host response to infection
Claudia Antonika, Durbadal Ojha, Pranav Danthi·bioRxiv·Jan 8, 2026
- RAB1B interacts with TRAF3 to promote antiviral innate immunity
D. C. Beachboard, M. Park, … S. M. Horner·bioRxiv·Feb 5, 2019
- Role of RIG-I-like receptors in innate immune sensing of Coxsackievirus B3 and encephalomyocarditis virus in murine macrophages and fibroblasts
Esther Francisco, Mehul Suthar, … Vincent R. Racaniello·bioRxiv·Oct 13, 2018
- Signaling from the RNA sensor RIG-I is regulated by ufmylation
D. L. Snider, M. Park, … S. M. Horner·bioRxiv·Oct 26, 2021
- Reovirus σ3 protein limits interferon expression and cell death induction
K. Roebke, Y. Guo, … P. Danthi·Journal of VirologyPeer-reviewed·Oct 27, 2020
- RTN3 inhibits RIGI-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination
Z. Yang, J. Wang, … E. Kuang·eLifePeer-reviewed·Jul 27, 2021